Emerging Data Show Promise With Immunotherapy Combos in NSCLC – OncLive
OncLive |
Emerging Data Show Promise With Immunotherapy Combos in NSCLC
OncLive OncLive: Can you discuss your presentation on combination trials with immunotherapy in patients with lung cancer? Patel: We have seen dramatic responses in subsets of patients with checkpoint blockade, particularly with the PD-1/PD-L1 axis. However … |
